for updates



Dr. Roger Bate analyses trends in drug development using data from the drug industry association, the Pharmaceutical Research and Manufacturers of America (PhRMA). The PhRMA data contains the worrying finding that far fewer AIDS drugs are in development compared to several years ago, and at a time when drug development for other communicable diseases is increasing.

There are several probable explanations for this phenomenon, but the least benign is the likelihood that continual pressure group and media attacks on the industry over pricing of drugs in Africa has reduced incentives for development of new AIDS medicines.

Download Saving Lives Today and Tomorrow (pdf format)

Contact the Author: Dr. Roger Bate

Phone: +1 202 431 5635

This page last updated April 21, 2003 - Comments, Questions, or Suggestions? -- Our Privacy Policy